22-hydroxycholesterol has been researched along with Angiogenesis, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordignon, C; Chiricozzi, E; Ciampa, MG; Daniele, S; Doglioni, C; Eberini, I; Feo, SG; Fontana, R; Gustafsson, JA; Lanterna, C; Leiva, A; Maggioni, D; Martini, C; Mauri, L; Mora, JR; Musumeci, A; Paniccia, A; Prinetti, A; Raccosta, L; Russo, V; Sensi, C; Sonnino, S; Sozzani, S; Steffensen, KR; Traversari, C; Trincavelli, ML; Villablanca, EJ | 1 |
1 other study(ies) available for 22-hydroxycholesterol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils.
Topics: Animals; Antigens, Ly; CD11b Antigen; Cell Proliferation; Chemotaxis; Chromatography, High Pressure Liquid; Disease Models, Animal; HEK293 Cells; Humans; Hydroxycholesterols; Immunosuppression Therapy; Ligands; Liver X Receptors; Mass Spectrometry; Mice; Myeloid Cells; Neoplasms; Neovascularization, Pathologic; Neutrophils; Orphan Nuclear Receptors; Receptors, G-Protein-Coupled; Receptors, Interleukin-8B; Signal Transduction; Sterols | 2013 |